Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 1
Response rate of the third and fourth doses of the BNT162b2 vaccine administered to cancer patients undergoing active anti-neoplastic treatments
Abed Agbarya, Ina Sarel, Tomer Ziv-Baran, Orna Schwartz, Yelena Shechtman, Ella Kozlener, Rasha Khoury, Mohammad Sheikh Ahmad, Leonard Saiegh, Forat Swaid, Ahmad Asala Abu, Urška Janžič, Ronen Brenner
Izvirni znanstveni članek
Oznake: SARS-CoV-2;BNT162b2 vaccine;cancer patients;anti-neoplastic treatment;chemotherapy;antibodies;immunogenicity;COVID-19;immunocompromise;
Response rate of the third and fourth doses of the BNT162b2 vaccine administered to cancer patients undergoing active anti-neoplastic treatments
Leto: 2023 Vir: Repozitorij Univerze v Ljubljani (RUL)
Št. zadetkov: 1
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: